Kazia Therapeutics Limited (KZIA)
Nasdaq: KZIA · Pharmaceutical Preparations · filing with the SEC since 2002
Who runs Kazia Therapeutics Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Friend John E. II
Chief Executive Officer. First filing Mar 2026, latest Jul 8, 2026, 0 filings in all.
Officers reporting now
6
of 9 people with a filing in the last fifteen months
Directors reporting now
3
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Friend John E. II | Chief Executive Officer | Mar 2026 | Jul 8, 2026 | none |
| Bonacorda Jeffrey | VP, Finance and Controller | Mar 2026 | Jul 8, 2026 | none |
| Cain David | Director, CMC | Apr 2026 | Jul 8, 2026 | none |
| Levine James E. | Chief Financial Officer | Jun 2026 | Jun 23, 2026 | none |
| Rao Sudha | Chief Scientific Officer | May 2026 | Jun 23, 2026 | none |
| Simpson Jeremy | Program Director | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Apple Robert F | director | Mar 2026 | Jul 8, 2026 | none |
| Coffey Steven R. S. | director | Mar 2026 | Jul 8, 2026 | none |
| Davidson Ebru | director | Jun 2026 | Jul 8, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.